trial · primary record
Zanidatamab
Biliary Tract Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 286 |
| Primary completion | 2030-04-01 |
| Primary endpoint | Progression Free Survival (PFS) in participants with Immunohistochemistry (IHC) 3+ tumors |
| Registry ID | NCT06282575 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:24.926Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06282575
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zanidatamab · compound